Cross-category comparison
Private Medication vs NHS Surgery
Different categories, normalised only where comparison is meaningful.
Private medication pathway
Clinical assessment by a regulated prescriber/provider; no NHS commissioning threshold required, but licence/clinical suitability still apply
VS
NHS bariatric surgery pathway
Referral + comprehensive specialist assessment + local commissioned service
How to use this comparison
Compare the factual differences below. We do not assign numerical treatment rankings: outcomes depend on the specific treatment, population, follow-up and your clinical circumstances.
Category-specific detail
| Issue | Private medication pathway | NHS bariatric surgery pathway |
|---|---|---|
| Access | Clinical assessment by a regulated prescriber/provider; no NHS commissioning threshold required, but licence/clinical suitability still apply | Referral + comprehensive specialist assessment + local commissioned service |
| Choice | Potentially broader choice among licensed treatments, subject to clinical suitability | Procedure choice based on specialist MDT, service capability and clinical factors |
| Continuity | Depends heavily on provider model and whether they communicate with GP | Strong NHS pathway/record integration |
| Cost | Ongoing private prescribing/medicine/service cost | No private surgical package fee |
| Eligibility | Private access does not mean everyone can be prescribed; licensed indications and safety still apply | NICE referral criteria are the starting point; referral is not a guarantee of surgery |
| Monitoring | Quality varies; safe services should independently verify information and provide appropriate review | Pre-op MDT, surgery, structured postoperative follow-up and long-term monitoring |
| Records | May sit outside NHS record unless information is shared | Integrated with NHS care |
| Speed | Often faster if provider has capacity | Can involve substantial waits and staged assessment |
Read both columns carefully.
A detail omitted from one column is not evidence that it is irrelevant to that treatment. Use the full guides and discuss clinical suitability with your treating team.
Sources & evidence
Check the underlying guidance directly: